J. P. Costantino

Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS

Irene Wapnir, James J. Dignam, Bernard Fisher et al. · JNCI Journal of the National Cancer Institute · 2011 · 780 citations · Full text

Medicine, Oncology, Surgery +12

OT2-06-02: A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) vs Partial Breast Irradiation (PBI) for Women with Stage 0, 1, or 2 Breast Cancer: NSABP B-39/RTOG 0413.

TB Julian, J. P. Costantino, F.A. Vicini et al. · Cancer Research · 2011 · 102 citations

Medicine, Oncology, Radiation Oncology +13

Abstract S1-03: Primary results from BETH, a phase 3 controlled study of adjuvant chemotherapy and trastuzumab ± bevacizumab in patients with HER2-positive, node-positive or high risk node-negative breast cancer

DJ Slamon, SM Swain, Marc Buyse et al. · Cancer Research · 2013 · 92 citations

Medicine, Oncology, Pharmacology +17

Five year update of cardiac dysfunction on NSABP B-31, a randomized trial of sequential doxorubicin/cyclophosphamide (AC)→paclitaxel (T) vs. AC→T with trastuzumab (H)

Priya Rastogi, Jong‐Hyeon Jeong, Charles E. Geyer et al. · Journal of Clinical Oncology · 2007 · 91 citations

Medicine, Oncology, Pharmacology +17

Early toxicity results with 3D conformal external beam therapy (CEBT) from the NSABP B-39/RTOG 0413 accelerated partial breast irradiation (APBI) trial.

Thomas B. Julian, J. P. Costantino, Frank A. Vicini et al. · Journal of Clinical Oncology · 2011 · 85 citations

Medicine, Oncology, Radiation Oncology +17